Broder; Christopher C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Broder; Christopher C..The latest application filed is for "soluble forms of hendra and nipah virus g glycoprotein".

Company Profile

1.18.28

Broder; Christopher C. - Silver Spring MD
Broder; Christopher C. - Rockville MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibodies against F glycoprotein of Hendra and Nipah viruses Grant 11,332,517 - Chan , et al. May 17, 2	2022-05-17
Soluble Forms of Hendra and Nipah Virus G Glycoprotein App 20210230230 - Broder; Christopher C. ; et al.	2021-07-29
Antibodies Against F Glycoprotein of Hendra and Nipah Viruses App 20210188950 - Chan; Yee-Peng ; et al.	2021-06-24
Antibodies against F glycoprotein of Hendra and Nipah viruses Grant 10,738,104 - Chan , et al. A	2020-08-11
Soluble Forms of Hendra and Nipah Virus G Glycoprotein App 20190031719 - Broder; Christopher C. ; et al.	2019-01-31
Antibodies Against F Glycoprotein of Hendra and Nipah Viruses App 20180298081 - CHAN; Yee-Peng ; et al.	2018-10-18
Soluble forms of Hendra and Nipah virus G glycoprotein Grant 10,053,495 - Broder , et al. August 21, 2	2018-08-21
Antibodies against F glycoprotein of Hendra and Nipah viruses Grant 9,982,038 - Chan , et al. May 29, 2	2018-05-29
Soluble Forms of Hendra and Nipah Virus G Glycoprotein App 20170174728 - Broder; Christopher C. ; et al.	2017-06-22
Soluble forms of hendra and nipah virus G glycoprotein Grant 9,533,038 - Broder , et al. January 3, 2	2017-01-03
Neutralizing Antibodies to Nipah and Hendra Virus App 20160272697 - Broder; Christopher C. ; et al.	2016-09-22
Soluble Forms of Hendra and Nipah Virus G Glycoprotein App 20150306208 - Broder; Christopher C. ; et al.	2015-10-29
Soluble forms of hendra and nipah virus G glycoprotein Grant 9,056,902 - Broder , et al. June 16, 2	2015-06-16
Soluble forms of Hendra and Nipah virus G glycoprotein Grant 9,045,532 - Broder , et al. June 2, 2	2015-06-02
Human Monoclonal Antibodies Against Hendra and Nipah Viruses App 20150071854 - Dimitrov; Dimiter S. ; et al.	2015-03-12
Hendra And Nipah Virus G Glycoprotein Immunogenic Compositions App 20150050305 - Elhay; Martin ; et al.	2015-02-19
Soluble forms of Hendra and Nipah virus G glycoprotein Grant 8,865,171 - Broder , et al. October 21, 2	2014-10-21
Human monoclonal antibodies against Hendra and Nipah viruses Grant 8,858,938 - Dimitrov , et al. October 14, 2	2014-10-14
Human Monoclonal Antibodies Against Hendra and Nipah Viruses App 20140079715 - Dimitrov; Dimiter S. ; et al.	2014-03-20
Neutralizing Antiboides to Nipah and Hendra Virus App 20140065166 - Broder; Christopher C. ; et al.	2014-03-06
Soluble Forms of Hendra and Nipah Virus G Glycoprotein App 20130171132 - Broder; Christopher C. ; et al.	2013-07-04
Soluble Forms of Hendra and Nipah Virus G Glycoprotein App 20130171131 - Broder; Christopher C. ; et al.	2013-07-04
Human Monoclonal Antibodies Against Hendra and Nipah Viruses App 20130149246 - Dimitrov; Dimiter S. ; et al.	2013-06-13
Human monoclonal antibodies against hendra and nipah viruses Grant 8,313,746 - Dimitrov , et al. November 20, 2	2012-11-20
Human Monoclonal Antibodies Against Hendra And Nipah Viruses App 20120064000 - Dimitrov; Dimiter S. ; et al.	2012-03-15
Composition and methods for the inhibition of membrane fusion by paramyxoviruses Grant 8,114,410 - Broder , et al. February 14, 2	2012-02-14
HIV-1 Immunogenic Compositions App 20110293697 - Quinnan; Gerald V. ; et al.	2011-12-01
Human monoclonal antibodies against Hendra and Nipah viruses Grant 7,988,971 - Dimitrov , et al. August 2, 2	2011-08-02
Composition and Methods for the Inhibition of Membrane Fusion by Paramyxoviruses App 20100184682 - Broder; Christopher C. ; et al.	2010-07-22
Compositions and methods for the inhibition of membrane fusion by paramyxoviruses Grant 7,666,431 - Broder , et al. February 23, 2	2010-02-23
Human Monoclonal Antibodies Against Hendra and Nipah Viruses App 20090214428 - Dimitrov; Dimiter S. ; et al.	2009-08-27
Soluble Forms of Hendra and Nipah Virus G Glycoprotein App 20090041772 - Broder; Christopher C. ; et al.	2009-02-12
Cc Chemokine Receptor 5 Dna, New Animal Models And Therapeutic Agents For Hiv Infection App 20080241167 - Combadiere; Christophe ; et al.	2008-10-02
CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection App 20070087990 - Combadiere; Christophe ; et al.	2007-04-19
CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection Grant 7,151,087 - Combadiere , et al. December 19, 2	2006-12-19
Compositions and methods for the inhibition of membrane fusion by paramyxoviruses App 20060233821 - Broder; Christopher C. ; et al.	2006-10-19
CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection App 20040259785 - Combadiere, Christophe ; et al.	2004-12-23
CC chemokine receptor 5 DNA, new animal models and therapeutic agents for HIV infection App 20030195348 - Combadiere, Christophe ; et al.	2003-10-16
Oligomeric HIV-1 envelope glycoproteins Grant 6,171,596 - Earl , et al. January 9, 2	2001-01-09

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.